Nanoparticles for targeted drug delivery to cancer stem cells: a review of recent advances

YN Ertas, K Abedi Dorcheh, A Akbari, E Jabbari - Nanomaterials, 2021 - mdpi.com
Cancer stem cells (CSCs) are a subpopulation of cells that can initiate, self-renew, and
sustain tumor growth. CSCs are responsible for tumor metastasis, recurrence, and drug …

Peptide-assembled nanoparticles targeting tumor cells and tumor microenvironment for cancer therapy

M Zhang, H Xu - Frontiers in Chemistry, 2023 - frontiersin.org
Tumor cells and corrupt stromal cells in the tumor microenvironment usually overexpress
cancer-specific markers that are absent or barely detectable in normal cells, providing …

Recombinant Proteins for Assembling as Nano-and Micro-Scale Materials for Drug Delivery: A Host Comparative Overview

JL Corchero, MTP Favaro, M Márquez-Martínez… - Pharmaceutics, 2023 - mdpi.com
By following simple protein engineering steps, recombinant proteins with promising
applications in the field of drug delivery can be assembled in the form of functional materials …

[HTML][HTML] Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles

C Martínez-Torró, L Alba-Castellón… - Biomedicine & …, 2023 - Elsevier
Two human proteins involved in the inflammatory cell death, namely Gasdermin D (GSDMD)
and the Mixed Lineage Kinase Domain-Like (MLKL) protein have been engineered to …

Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by …

H Chen, J Deng, X Yao, Y He, H Li, Z Jian… - Journal of …, 2021 - Springer
Background Jaw bones are the most common organs to be invaded by oral malignancies,
such as oral squamous cell carcinoma (OSCC), because of their special anatomical …

Time-prolonged release of tumor-targeted protein–MMAE nanoconjugates from implantable hybrid materials

N Serna, A Falgàs, A García-León, U Unzueta… - Pharmaceutics, 2022 - mdpi.com
The sustained release of small, tumor-targeted cytotoxic drugs is an unmet need in cancer
therapies, which usually rely on punctual administration regimens of non-targeted drugs …

Toxicity and cytotoxicity effects of selected nanoparticles: a review

OR Odaudu, AA Akinsiku - IOP Conference Series: Earth and …, 2022 - iopscience.iop.org
The appreciable development in nanotechnology has drawn the attention of several
researchers cutting across different fields. However, some nanoparticles have been …

Chemical modifications in nucleic acids for therapeutic and diagnostic applications

C Fàbrega, A Aviñó, R Eritja - The Chemical Record, 2022 - Wiley Online Library
The last decade has witnessed the blooming of nucleic acids for therapeutic and diagnostic
applications. In the present article, we describe the most important results from our group in …

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4+ Cancers

O Cano-Garrido, P Álamo, L Sánchez-García, A Falgàs… - Cancers, 2021 - mdpi.com
Simple Summary Aimed at minimizing side toxicities cancer therapies require appropriate
functional vehicles at the nanoscale, for receptor-mediated tumor-targeted drug delivery …

[HTML][HTML] High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles

E Voltà-Durán, L Alba-Castellón, N Serna, I Casanova… - Acta biomaterialia, 2023 - Elsevier
The need for more effective and precision medicines for cancer has pushed the exploration
of new materials appropriate for drug delivery and imaging, and alternative receptors for …